1.COVID-19 antibodies in convalescent plasma donations wane by 3 to 4 months-02/10/2020
2.Wanted in Covid-19 Fight: Superdonors of Convalescent Plasma-02/10/2020
3.NIH expands trials of convalescent plasma against Covid-19-27/09/2020
4.Promoting access to COVID-19 convalescent plasma in low- and middle-income countries-27/09/2020
5.Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis-27/09/2020
6.Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease-27/09/2020
7.Therapeutic options in the treatment of severe acute respiratory syndrome coronavirus 2 in pregnant patient-27/09/2020
8.Convalescent plasma from COVID 19 patients enhances intensive care unit survival rate. A preliminary report-27/09/2020
10.Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study-27/09/2020
11.SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma-27/09/2020
12.Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience-27/09/2020
13.Convalescent plasma for COVID-19-27/09/2020
15.COVID-19 RESEARCH-27/09/2020